FDA authorizes use of diabetes drug tirzepatide for weight loss

The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication.

Related Keywords

United States ,Indiana ,John Sharretts ,Drug Administration On ,Drug Administration ,Indianapolis Based Lilly ,Drug Evaluation ,Lilly Diabetes ,Food And Drug Administration ,Diabetes Medication ,Weight Management ,Weight Loss ,Fda Approved ,